Pingora Partners’s AbbVie ABBV Stock Holding History

Pingora Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$371K	Hold	1,705	–	–	0.22%	61
2025 Q4	$390K	Sell	1,705 -50	-3%	-$11.4K	0.24%	54
2025 Q3	$406K	Hold	1,755	–	–	0.27%	50
2025 Q2	$326K	Hold	1,755	–	–	0.24%	57
2025 Q1	$368K	Sell	1,755 -85	-5%	-$16.5K	0.27%	52
2024 Q4	$327K	Sell	1,840 -800	-30%	-$147K	0.21%	53
2024 Q3	$521K	Hold	2,640	–	–	0.37%	39
2024 Q2	$453K	Hold	2,640	–	–	0.32%	41
2024 Q1	$481K	Buy	2,640 +1,190	+82%	+$205K	0.35%	43
2023 Q4	$225K	Buy	+1,450	New	+$211K	0.2%	64

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pingora Partners's ABBV Position: Q1 2026 in Review

Pingora Partners held its AbbVie (ABBV) position steady in Q1 2026 at 1,705 shares worth $371K. The position accounts for 0.22% of the portfolio, ranked #61.

Pingora Partners first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $521K in Q3 2024. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Pingora Partners held 1,705 shares of AbbVie worth $371K as of Q1 2026.
Pingora Partners left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.22% of Pingora Partners's portfolio in Q1 2026, its #61 holding.
Pingora Partners first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Pingora Partners's AbbVie position peaked at $521K in Q3 2024.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Pingora Partners's 13F filing for Q1 2026, filed 15 May 2026.